Skip to content
2000
Volume 22, Issue 4
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Objective: Lung cancer is the most prevalent cancer in the world, and lung adenocarcinoma is the most common lung cancer subtype. Identification and determination of relevant prognostic markers are the key steps to personalized cancer management. Methods: We collected the gene expression profiles from 265 tumor tissues of stage I patients from The Cancer Genome Atlas (TCGA) databases. Using Cox regression model, we evaluated the association between gene expression and the overall survival time of patients adjusting for gender and age at initial pathologic diagnosis. Results: Age at initial pathologic diagnosis was identified to be associated with the survival, while gender was not. We identified that 15 genes were significantly associated with overall survival time of patients (FDR < 0.1). The 15-mRNA signature- based risk score was helpful to distinguish patients of high-risk group from patients of low-risk group. Conclusion: Our findings reveal novel genes associated with lung adenocarcinoma survival and extend our understanding of how gene expression contributes to lung adenocarcinoma survival. These results are helpful for the prediction of the prognosis and personalized cancer management.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207322666190404152140
2019-05-01
2025-07-13
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207322666190404152140
Loading

  • Article Type:
    Research Article
Keyword(s): cancer management; gene; Lung adenocarcinoma; lung cancer; markers; prognosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test